• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PP1 与 ASPP2 合作使 TAZ 去磷酸化并激活。

PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.

机构信息

Key Laboratory of Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology School of Medicine, Lab, Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.

出版信息

J Biol Chem. 2011 Feb 18;286(7):5558-66. doi: 10.1074/jbc.M110.194019. Epub 2010 Dec 28.

DOI:10.1074/jbc.M110.194019
PMID:21189257
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3037669/
Abstract

The Hippo pathway regulates organ size by controlling both cell proliferation and apoptosis. TAZ functions as a transcriptional co-activator downstream of the Hippo pathway and has been implicated in human cancer development. A key step in the Hippo-TAZ pathway is phosphorylation of TAZ by LATS kinase, which leads to TAZ inhibition by both cytoplasmic retention and degradation. However, the mechanism of TAZ dephosphorylation and the responsible phosphatase are unknown. Here, we identified PP1 as a bona fide TAZ phosphatase. PP1A dephosphorylates TAZ at Ser-89 and Ser-311, promotes TAZ nuclear translocation, and stabilizes TAZ by disrupting the binding to the SCF E3 ubiquitin ligase. Furthermore, ASPP2 facilitates the interaction between TAZ and PP1 to promote TAZ dephosphorylation. As a result, PP1 and ASPP2 increase TAZ-dependent gene expression. This study demonstrates that PP1A and ASPP2 play a critical role in promoting TAZ function by antagonizing the LATS kinase through TAZ dephosphorylation.

摘要

Hippo 通路通过控制细胞增殖和细胞凋亡来调节器官大小。TAZ 作为 Hippo 通路的下游转录共激活因子,与人类癌症的发展有关。Hippo-TAZ 通路的一个关键步骤是 LATS 激酶对 TAZ 的磷酸化,这导致 TAZ 通过细胞质滞留和降解而被抑制。然而,TAZ 去磷酸化的机制和负责的磷酸酶尚不清楚。在这里,我们鉴定出 PP1 是 TAZ 的一种真正的磷酸酶。PP1A 在 Ser-89 和 Ser-311 处使 TAZ 去磷酸化,促进 TAZ 核易位,并通过破坏与 SCF E3 泛素连接酶的结合来稳定 TAZ。此外,ASPP2 促进 TAZ 与 PP1 之间的相互作用,从而促进 TAZ 的去磷酸化。结果,PP1 和 ASPP2 通过 TAZ 去磷酸化来增加 TAZ 依赖性基因表达。这项研究表明,PP1A 和 ASPP2 通过 TAZ 去磷酸化拮抗 LATS 激酶,在促进 TAZ 功能方面发挥着关键作用。

相似文献

1
PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ.PP1 与 ASPP2 合作使 TAZ 去磷酸化并激活。
J Biol Chem. 2011 Feb 18;286(7):5558-66. doi: 10.1074/jbc.M110.194019. Epub 2010 Dec 28.
2
A cell-based screening for TAZ activators identifies ethacridine, a widely used antiseptic and abortifacient, as a compound that promotes dephosphorylation of TAZ and inhibits adipogenesis in C3H10T1/2 cells.一项基于细胞的TAZ激活剂筛选确定了吖啶黄,一种广泛使用的防腐剂和堕胎药,作为一种能促进TAZ去磷酸化并抑制C3H10T1/2细胞脂肪生成的化合物。
J Biochem. 2015 Nov;158(5):413-23. doi: 10.1093/jb/mvv051. Epub 2015 May 14.
3
The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.河马肿瘤通路通过磷酸化磷酸降解部位并募集 SCF{beta}-TrCP E3 连接酶来促进 TAZ 的降解。
J Biol Chem. 2010 Nov 26;285(48):37159-69. doi: 10.1074/jbc.M110.152942. Epub 2010 Sep 21.
4
The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.N 端磷酸肽降解结构域通过 SCFβ-TrCP 介导的泛素化途径靶向 TAZ/WWTR1 蛋白降解,从而对磷酸肌醇 3-激酶抑制剂产生应答。
J Biol Chem. 2012 Jul 27;287(31):26245-53. doi: 10.1074/jbc.M112.382036. Epub 2012 Jun 12.
5
Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation.PP1A 磷酸酶使转录共激活因子 NACA 去磷酸化,增强 cJUN 的转录活性和成骨细胞分化。
J Biol Chem. 2019 May 17;294(20):8184-8196. doi: 10.1074/jbc.RA118.006920. Epub 2019 Apr 4.
6
PARD3 induces TAZ activation and cell growth by promoting LATS1 and PP1 interaction.PARD3通过促进LATS1与PP1相互作用诱导TAZ激活和细胞生长。
EMBO Rep. 2015 Aug;16(8):975-85. doi: 10.15252/embr.201439951. Epub 2015 Jun 26.
7
PP1A-mediated dephosphorylation positively regulates YAP2 activity.PP1A 介导的去磷酸化正向调节 YAP2 活性。
PLoS One. 2011;6(9):e24288. doi: 10.1371/journal.pone.0024288. Epub 2011 Sep 1.
8
The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.非受体酪氨酸激酶 c-Src 减弱了 SCF(β-TrCP) E3 连接酶的活性,从而阻止了 Taz 的蛋白酶体降解。
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1678-1683. doi: 10.1073/pnas.1610223114. Epub 2017 Feb 1.
9
Arhgef7 promotes activation of the Hippo pathway core kinase Lats.Arhgef7促进Hippo信号通路核心激酶Lats的激活。
EMBO J. 2014 Dec 17;33(24):2997-3011. doi: 10.15252/embj.201490230. Epub 2014 Nov 25.
10
Histone Deacetylase Inhibitors Target the Leukemic Microenvironment by Enhancing a Nherf1-Protein Phosphatase 1α-TAZ Signaling Pathway in Osteoblasts.组蛋白去乙酰化酶抑制剂通过增强成骨细胞中的Nherf1-蛋白磷酸酶1α-TAZ信号通路靶向白血病微环境。
J Biol Chem. 2015 Dec 4;290(49):29478-92. doi: 10.1074/jbc.M115.668160. Epub 2015 Oct 21.

引用本文的文献

1
Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities.YAP/TAZ的翻译后修饰:分子机制与治疗机遇
Cell Mol Biol Lett. 2025 Jul 17;30(1):83. doi: 10.1186/s11658-025-00760-4.
2
CEMIP Maintains Vascular Contractility by Controlling PP1c-MLC20 Cascade in SMCs.CEMIP通过控制平滑肌细胞中的PP1c-MLC20级联反应维持血管收缩性。
Circ Res. 2025 Aug;137(4):519-532. doi: 10.1161/CIRCRESAHA.125.326233. Epub 2025 Jul 1.
3
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.肝脏修复与再生的分子机制:从生理学到治疗学
Signal Transduct Target Ther. 2025 Feb 8;10(1):63. doi: 10.1038/s41392-024-02104-8.
4
Inhibited peroxidase activity of peroxiredoxin 1 by palmitic acid exacerbates nonalcoholic steatohepatitis in male mice.棕榈酸抑制过氧化物还原酶1的过氧化物酶活性会加重雄性小鼠的非酒精性脂肪性肝炎。
Nat Commun. 2025 Jan 11;16(1):598. doi: 10.1038/s41467-025-55939-2.
5
The Hippo Pathway in Breast Cancer: The Extracellular Matrix and Hypoxia.乳腺癌中的河马信号通路:细胞外基质与缺氧
Int J Mol Sci. 2024 Nov 29;25(23):12868. doi: 10.3390/ijms252312868.
6
PCYT2 inhibits epithelial-mesenchymal transition in colorectal cancer by elevating YAP1 phosphorylation.PCYT2通过提高YAP1磷酸化水平来抑制结直肠癌中的上皮-间质转化。
JCI Insight. 2024 Dec 20;9(24):e178823. doi: 10.1172/jci.insight.178823.
7
Advancements of anticancer agents by targeting the Hippo signalling pathway: biological activity, selectivity, docking analysis, and structure-activity relationship.通过靶向Hippo信号通路的抗癌药物研究进展:生物活性、选择性、对接分析及构效关系
Mol Divers. 2025 Jun;29(3):2829-2862. doi: 10.1007/s11030-024-11009-1. Epub 2024 Oct 22.
8
Pan-cancer analysis of the prognostic and immunological role of hippo-YAP signaling pathway.河马-YAP信号通路的预后及免疫作用的泛癌分析
Discov Oncol. 2024 Sep 27;15(1):504. doi: 10.1007/s12672-024-01212-9.
9
Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development.沉默调节蛋白5介导的TAZ在K54位点的去乙酰化促进黑色素瘤发展。
Cell Oncol (Dordr). 2024 Jun;47(3):967-985. doi: 10.1007/s13402-023-00910-w. Epub 2023 Dec 19.
10
ASPP2 Is Phosphorylated by CDK1 during Mitosis and Required for Pancreatic Cancer Cell Proliferation.ASPP2在有丝分裂期间被CDK1磷酸化,是胰腺癌细胞增殖所必需的。
Cancers (Basel). 2023 Nov 15;15(22):5424. doi: 10.3390/cancers15225424.

本文引用的文献

1
The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.河马肿瘤通路通过磷酸化磷酸降解部位并募集 SCF{beta}-TrCP E3 连接酶来促进 TAZ 的降解。
J Biol Chem. 2010 Nov 26;285(48):37159-69. doi: 10.1074/jbc.M110.152942. Epub 2010 Sep 21.
2
Combined functional genomic and proteomic approaches identify a PP2A complex as a negative regulator of Hippo signaling.联合功能基因组学和蛋白质组学方法鉴定出一个 PP2A 复合物,它是 Hippo 信号的负调控因子。
Mol Cell. 2010 Aug 27;39(4):521-34. doi: 10.1016/j.molcel.2010.08.002.
3
The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.Hippo-YAP 通路在器官大小控制和肿瘤发生中的作用:更新版本。
Genes Dev. 2010 May;24(9):862-74. doi: 10.1101/gad.1909210.
4
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation.YAP1在刺猬信号相关的髓母细胞瘤中扩增并上调,介导音猬因子驱动的神经前体细胞增殖。
Genes Dev. 2009 Dec 1;23(23):2729-41. doi: 10.1101/gad.1824509.
5
Serine/threonine phosphatases: mechanism through structure.丝氨酸/苏氨酸磷酸酶:基于结构的作用机制
Cell. 2009 Oct 30;139(3):468-84. doi: 10.1016/j.cell.2009.10.006.
6
TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.TEAD转录因子介导TAZ在细胞生长和上皮-间质转化中的功能。
J Biol Chem. 2009 May 15;284(20):13355-13362. doi: 10.1074/jbc.M900843200. Epub 2009 Mar 26.
7
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.TAZ在乳腺癌细胞迁移、侵袭及肿瘤发生中的作用。
Cancer Res. 2008 Apr 15;68(8):2592-8. doi: 10.1158/0008-5472.CAN-07-2696.
8
TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway.TAZ促进细胞增殖和上皮-间质转化,并受到河马通路的抑制。
Mol Cell Biol. 2008 Apr;28(7):2426-36. doi: 10.1128/MCB.01874-07. Epub 2008 Jan 28.
9
Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ.缺乏TAZ的小鼠出现多发性肾囊肿、尿浓缩功能缺陷和肺气肿改变。
Am J Physiol Renal Physiol. 2008 Mar;294(3):F542-53. doi: 10.1152/ajprenal.00201.2007. Epub 2008 Jan 2.
10
Tumor suppressor LATS1 is a negative regulator of oncogene YAP.肿瘤抑制因子LATS1是致癌基因YAP的负调控因子。
J Biol Chem. 2008 Feb 29;283(9):5496-509. doi: 10.1074/jbc.M709037200. Epub 2007 Dec 24.